{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:31:45Z","timestamp":1794947505976,"version":"4.9.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To compare the real-life screening outcomes after cytology was replaced by human papillomavirus (HPV) testing for women aged 60\u201364 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Using the Danish national pathology register, we compared screening outcomes during two consecutive calendar periods, one where women were screened with cytology and one where most women were screened with HPV testing. Our primary outcomes were the proportions of women with positive test results, high-grade cervical intraepithelial neoplasia (CIN 2 or worse), and cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Women screened during the HPV testing period were more likely to have a positive screening test result than were women screened during the cytology period (relative proportion 2.80, 95% CI 2.65\u20132.96). The detection of CIN 2 or worse was also increased (relative proportion 1.54, 95% CI 1.31\u20131.80), whereas there was no increase in screen-detected cervical cancer diagnoses (relative proportion 1.27, 95% CI 0.76\u20132.12). Within the first 4 years after a negative screening test result, including 168,477 woman-years at risk after a negative screen result in the HPV period and 451,421 woman-years after a negative screen result in the cytology period, the risk of a cervical cancer diagnosis was approximately 4 per 100,000 woman-years and was similar for both screening tests (relative risk 0.99, 95% CI 0.41\u20132.35).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Human papillomavirus testing led to more positive screening test results and diagnoses of high-grade CIN lesions. Few women were diagnosed with cervical cancer after a negative screening test result.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004522","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T18:00:07Z","timestamp":1628186407000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60\u201364 Years"],"prefix":"10.1097","volume":"138","author":[{"given":"Jeppe Bennekou","family":"Schroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Rafiolsadat","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matejka","family":"Rebolj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med"},{"key":"R3-20261117","first-page":"77","article-title":"A first survey of HPV-based screening in routine cervical cancer screening in Italy","volume":"39","author":"Ronco","year":"2015","journal-title":"Epidemiol Prev"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/096914106776179773","article-title":"What happens when organization of cervical cancer screening is delayed or stopped?","volume":"13","author":"Lynge","year":"2006","journal-title":"J Med Screen"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ejca.2015.04.012","article-title":"A daunting challenge: human papillomavirus assays and cytology in primary cervical screening of women below age 30 years","volume":"51","author":"Rebolj","year":"2015","journal-title":"Eur J Cancer"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"e0147326","DOI":"10.1371\/journal.pone.0147326","article-title":"Human papillomavirus assays and cytology in primary cervical screening of women aged 30 Years and above","volume":"11","author":"Rebolj","year":"2016","journal-title":"PLoS One"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ypmed.2018.07.005","article-title":"How confident can we be in the current guidelines for exiting cervical screening?","volume":"114","author":"Gravitt","year":"2018","journal-title":"Prev Med"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12889-015-2039-0","article-title":"Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study","volume":"15","author":"Tranberg","year":"2015","journal-title":"BMC Public Health"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3109\/0284186X.2015.1016625","article-title":"Hysterectomy and its impact on the calculated incidence of cervical cancer and screening coverage in Denmark","volume":"54","author":"Lam","year":"2015","journal-title":"Acta Oncol"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish pathology register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cyt.12451","article-title":"Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening","volume":"28","author":"Rebolj","year":"2017","journal-title":"Cytopathology"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/bjc.2015.339","article-title":"Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark","volume":"113","author":"Rebolj","year":"2015","journal-title":"Br J Cancer"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canep.2013.12.007","article-title":"Predictors of non-participation in cervical screening in Denmark","volume":"38","author":"Kristensson","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/bjc.2014.362","article-title":"50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence","volume":"111","author":"Vaccarella","year":"2014","journal-title":"Br J Cancer"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"e1001585","DOI":"10.1371\/journal.pmed.1001585","article-title":"Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study","volume":"11","author":"Casta\u00f1\u00f3n","year":"2014","journal-title":"PLoS Med"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygyno.2019.04.680","article-title":"HPV-prevalence in elderly women in Denmark","volume":"154","author":"Andersen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.maturitas.2014.09.012","article-title":"Role of cervical screening in older women","volume":"79","author":"Elit","year":"2014","journal-title":"Maturitas"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/ijc.26248","article-title":"Frequency of cervical intraepithelial neoplasia treatment in a well-screened population","volume":"130","author":"Barken","year":"2012","journal-title":"Int J Cancer"},{"key":"R27-20261117","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/aje\/kwt077","article-title":"Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data","volume":"178","author":"Vink","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R28-20261117","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/sj.bjc.6601355","article-title":"Extended duration of the detectable stage by adding HPV test in cervical cancer screening","volume":"89","author":"van den Akker-van Marie","year":"2003","journal-title":"Br J Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:00:42Z","timestamp":1794945642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004522","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"2021-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}